These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 25141979)

  • 41. Gramicidin S: a peptide model for protein glycation and reversal of glycation using nucleophilic amines.
    Shakkottai VG; Sudha R; Balaram P
    J Pept Res; 2002 Aug; 60(2):112-20. PubMed ID: 12102724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metal attenuating therapies in neurodegenerative disease.
    Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
    Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease.
    Takeuchi M; Kikuchi S; Sasaki N; Suzuki T; Watai T; Iwaki M; Bucala R; Yamagishi S
    Curr Alzheimer Res; 2004 Feb; 1(1):39-46. PubMed ID: 15975084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2'-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species.
    Rafi Z; Alouffi S; Khan MS; Ahmad S
    Curr Protein Pept Sci; 2020; 21(9):924-935. PubMed ID: 32053073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products.
    Ashraf JM; Rabbani G; Ahmad S; Hasan Q; Khan RH; Alam K; Choi I
    PLoS One; 2015; 10(6):e0130630. PubMed ID: 26121680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycation accelerates fibrillization of the amyloidogenic W7FW14F apomyoglobin.
    Iannuzzi C; Maritato R; Irace G; Sirangelo I
    PLoS One; 2013; 8(12):e80768. PubMed ID: 24324625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary natural products as a potential inhibitor towards advanced glycation end products and hyperglycemic complications: A phytotherapy approaches.
    M V; Wang K
    Biomed Pharmacother; 2021 Dec; 144():112336. PubMed ID: 34678719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
    Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Bioactives in Neurodegenerative Diseases.
    Zacharia LC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.
    Do HTT; Cho J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of wedelolactone in the anti-glycation and anti-diabetic activity in experimental diabetic animals.
    Shahab U; Faisal M; Alatar AA; Ahmad S
    IUBMB Life; 2018 Jun; 70(6):547-552. PubMed ID: 29624857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptor for advanced glycation end-products in neurodegenerative diseases.
    Juranek J; Ray R; Banach M; Rai V
    Rev Neurosci; 2015; 26(6):691-8. PubMed ID: 26226128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 58. Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases.
    Natale G; Pompili E; Biagioni F; Paparelli S; Lenzi P; Fornai F
    Eur J Histochem; 2013 Mar; 57(1):e5. PubMed ID: 23549464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycation induces formation of amyloid cross-beta structure in albumin.
    Bouma B; Kroon-Batenburg LM; Wu YP; Brünjes B; Posthuma G; Kranenburg O; de Groot PG; Voest EE; Gebbink MF
    J Biol Chem; 2003 Oct; 278(43):41810-9. PubMed ID: 12909637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbonyl toxicology and Alzheimer's disease.
    Picklo MJ; Montine TJ; Amarnath V; Neely MD
    Toxicol Appl Pharmacol; 2002 Nov; 184(3):187-97. PubMed ID: 12460747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.